Status:
RECRUITING
Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Lead Sponsor:
Tanta University
Conditions:
Enlarged Prostate With Lower Urinary Tract Symptoms
Eligibility:
MALE
40-70 years
Phase:
PHASE3
Brief Summary
The main objective of this prospective randomized controlled study is to compare safety and efficacy of Vardenafil versus Tadalafil versus Tamsulosin in terms of (voiding function, sexual function and...
Detailed Description
This is prospective randomized controlled study that will be conducted on men with BPH related LUTS amenable to medical treatment at Urology Department, Faculty of Medicine, Tanta University - Egypt a...
Eligibility Criteria
Inclusion
- Sexually active patients .
- ModerateBPH related LUTS ( bengin prostatic hyperplasia related lower urinary tract symtoms ) i.e: (international prostatic symptom score 8 to 19 : the higher score is the worse symptoms ).
- Patients accepted medical treatment and completed 12 weeks on medical treatment and strict follow up .
Exclusion
- Indication for combined therapy as prostate size over 40 gm .
- Gross hematuria.
- Refractory urine retention .
- Bilateral hydro-ureteronephrosis or renal insufficiency secondary to bengin prostatic hyperplasia.
- Bladder diverticula or calculi .
- History of bladder or prostate cancer.
- Unwilling patients to medical therapy.
- History of pelvic surgery or urethral stricture.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06491108
Start Date
June 1 2024
End Date
July 1 2025
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculity of medicine - Tanta university
Tanta, Gharbia Governorate, Egypt, 31528